Next-generation Sequencing Data Analysis Market Size, Share & Trends Analysis Report By Product (Services, NGS Commercial Software), By Workflow (Primary, Secondary), By Mode, By Read Length, By End Use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Next-generation Sequencing Data Analysis Market Growth & Trends
The global next-generation sequencing data analysis market size is estimated treach USD 3.45 billion by 2030, expanding at a CAGR of 23.10% from 2025 t2030, according ta new report by Grand View Research, Inc. The growth can be attributed ta significant decline in the cost of NGS installation in clinical diagnosis. Furthermore, the accessibility of genomic and proteomic data is anticipated tcreate significant growth opportunities. In addition, a reduction in the cost of sequencing is anticipated tboost the adoption rate of NGS, which would further drive the industry. The availability of tools, such as the Targeted Methyl-Seq platform and Agilent’s HaloPlex capture system from EpiGentek Group Inc. has aided in the DNA methylation profiles determination in individual genomes. The COVID-19 pandemic has enhanced NGS usage and has created a huge demand.
The NGS tools can generate a significant amount of data for scientists tanalyze and study pathogenesis. Researchers from industry, academia, and government have used data analysis technology thelp in understanding the characteristics, phylogenetics, and processes of SARS-CoV2. NGS technologies have helped tunveil biological information that has not been studied yet using conventional technologies. For instance, NGS has helped study genomic patterns associated with various biological processes and epigenomics. However, issues related taccessing storage management, and analysis of data are anticipated toffer huge R&D prospects, thus, driving the industry growth. Researchers that use high-throughput sequencers demand software systems, such as Laboratory Information Management Systems (LIMS) tarchive and handle sequencing information.
Furthermore, the introduction of workflow management system solutions, such as Galaxy and Chipster, drives demand for technological advancements in data storage and management. Demand for technologically advanced infrastructure tmonitor the flow of data analysis process from data generation tpreliminary analysis thigher-level analysis has increased. Moreover, NGS data analysis tools are being constantly upgraded for obtaining effective results and higher utility. For instance, in December 2021, BionanGenomics launched BioDiscovery’s NxClinical Software Version 6.1 for genome analysis. The version enables enhanced visualization and interpretation of NGS data for cancer and genetic disease domains. Such developments are anticipated tdrive the industry over the forecast period.
Next-generation Sequencing Data Analysis Market Report Highlights
Next-generation Sequencing Data Analysis Market Growth & Trends
The global next-generation sequencing data analysis market size is estimated treach USD 3.45 billion by 2030, expanding at a CAGR of 23.10% from 2025 t2030, according ta new report by Grand View Research, Inc. The growth can be attributed ta significant decline in the cost of NGS installation in clinical diagnosis. Furthermore, the accessibility of genomic and proteomic data is anticipated tcreate significant growth opportunities. In addition, a reduction in the cost of sequencing is anticipated tboost the adoption rate of NGS, which would further drive the industry. The availability of tools, such as the Targeted Methyl-Seq platform and Agilent’s HaloPlex capture system from EpiGentek Group Inc. has aided in the DNA methylation profiles determination in individual genomes. The COVID-19 pandemic has enhanced NGS usage and has created a huge demand.
The NGS tools can generate a significant amount of data for scientists tanalyze and study pathogenesis. Researchers from industry, academia, and government have used data analysis technology thelp in understanding the characteristics, phylogenetics, and processes of SARS-CoV2. NGS technologies have helped tunveil biological information that has not been studied yet using conventional technologies. For instance, NGS has helped study genomic patterns associated with various biological processes and epigenomics. However, issues related taccessing storage management, and analysis of data are anticipated toffer huge R&D prospects, thus, driving the industry growth. Researchers that use high-throughput sequencers demand software systems, such as Laboratory Information Management Systems (LIMS) tarchive and handle sequencing information.
Furthermore, the introduction of workflow management system solutions, such as Galaxy and Chipster, drives demand for technological advancements in data storage and management. Demand for technologically advanced infrastructure tmonitor the flow of data analysis process from data generation tpreliminary analysis thigher-level analysis has increased. Moreover, NGS data analysis tools are being constantly upgraded for obtaining effective results and higher utility. For instance, in December 2021, BionanGenomics launched BioDiscovery’s NxClinical Software Version 6.1 for genome analysis. The version enables enhanced visualization and interpretation of NGS data for cancer and genetic disease domains. Such developments are anticipated tdrive the industry over the forecast period.
Next-generation Sequencing Data Analysis Market Report Highlights
- The services product segment dominated the industry in 2024. NGS has several advantages, in terms of speed and affordability, and many research institutes are unable tadopt it due ta lack of skilled professionals and sufficient computational infrastructure.
- The tertiary analysis workflow segment captured the major revenue share in 2024 as it accounts for the complex and important step of NGS, which is linked with the interpretation of the results.
- The in-house mode segment dominated the market in 2024 and is anticipated tremain dominant in the coming years. However, the outsourced mode segment is anticipated twitness the fastest growth rate from 2025 t2030 owing ttime and cost advantages.
- The short-read sequencing segment held the maximum share in 2024 due tthe high adoption of short-read sequencing techniques and their cost-effective nature & ability twork with DNA fragments and the availability of several tools & algorithms.
- The academic research end-use segment dominated the market in 2024. A reduction in the NGS technology cost has fueled the NGS software platforms usage by several research centers & academic institutions for their research that require data interpretation.
- North America captured the highest revenue share in 2024 owing tthe presence of well-developed information technology companies, favorable reimbursement network, and high government funding and high public & private expenditures in the biotechnology sector.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.1.1. Product Segment
1.1.2. Workflow Segment
1.1.3. Mode Segment
1.1.4. Read Length Segment
1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Demand for efficient algorithms and tools for analysis of large amount of data generated by sequencers
3.2.1.2. Introduction of technological advancements in cloud computing and data integration
3.2.1.3. Increasing penetration of the NGS technology in personalized medicine and precision diagnosis
3.2.1.4. Rising academic research based on NGS protocols
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges in sequence compression and data storage
3.2.2.2. Selection of appropriate algorithms and parallelizing scientific workflows
3.2.2.3. Budget and time constraints
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. PRODUCT GROUP BUSINESS ANALYSIS
4.1. Product Segment Dashboard
4.2. Next-generation Sequencing Data Analysis Market Product Movement Analysis
4.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Services
4.4.1. Services market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. NGS Commercial Software
4.5.1. NGS commercial software market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2. Platform OS/UI
4.5.2.1. Platform OS/UI market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Analytical Software
4.5.3.1. Analytical software market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.2. QC/pre-processing tools
4.5.3.2.1. QC/pre-processing tools market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3. Alignment tools & software
4.5.3.3.1. Alignment tools & software market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3.2. DNA sequencing alignment
4.5.3.3.2.1. DNA sequencing alignment market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3.3. RNA sequencing alignment
4.5.3.3.3.1. RNA sequencing alignment market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3.4. Protein sequencing alignment
4.5.3.3.4.1. Protein sequencing alignment market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.4. Others
4.5.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. WORKFLOW GROUP BUSINESS ANALYSIS
5.1. Workflow Segment Dashboard
5.2. Next-generation Sequencing Data Analysis Market Workflow Movement Analysis
5.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Primary
5.4.1. Primary market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Secondary
5.5.1. Secondary market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. Read Mapping
5.5.2.1. Read mapping market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Variant Alignment & Variant Calling
5.5.3.1. Variant alignment & variant calling market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Tertiary
5.6.1. Tertiary market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Variant Annotation
5.6.2.1. Variant annotation market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. Application Specific
5.6.3.1. Application specific market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.2. Targeted Sequencing/Gene Panel
5.6.3.2.1. Targeted sequencing/gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.3. Exome
5.6.3.3.1. Exome market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.4. RNA Sequencing
5.6.3.4.1. RNA sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.5. Whole Genome
5.6.3.5.1. Whole genome market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.6. Chip Sequencing
5.6.3.6.1. Chip sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.7. Others
5.6.3.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. MODE GROUP BUSINESS ANALYSIS
6.1. Mode Segment Dashboard
6.2. Next-generation Sequencing Data Analysis Market Mode Movement Analysis
6.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
6.4. In-house Data Analysis
6.4.1. In-house data analysis market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Outsourced Data Analysis
6.5.1. Outsourced data analysis market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. READ LENGTH GROUP BUSINESS ANALYSIS
7.1. Read Length Segment Dashboard
7.2. Next-generation Sequencing Data Analysis Market Read Length Movement Analysis
7.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Read Length, 2018 to 2030 (USD Million)
7.4. Short Read Sequencing
7.4.1. Short read sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Long Read Sequencing
7.5.1. Long read sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Very Long Read Sequencing
7.6.1. Very long read sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. END USE BUSINESS ANALYSIS
8.1. End Use Segment Dashboard
8.2. Next-generation Sequencing Data Analysis Market End Use Movement Analysis
8.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Academic Research
8.4.1. Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Clinical Research
8.5.1. Clinical research market estimates and forecasts, 2018–2030 (USD Million)
8.6. Hospitals & Clinics
8.6.1. Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Pharma & Biotech Entities
8.7.1. Pharma& biotech entities market estimates and forecasts, 2018–2030 (USD Million)
8.8. Other
8.8.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. REGIONAL BUSINESS ANALYSIS BY PRODUCT, WORKFLOW, MODE, READ LENGTH, END USE
9.1. Regional Dashboard
9.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
9.3. North America
9.3.1. North America Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. U.S. Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Canada Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Mexico Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. Europe Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. UK Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Germany Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. France Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Italy Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Spain Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Denmark Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Competitive Scenario
9.4.8.3. Sweden Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Competitive Scenario
9.4.9.3. Norway Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.2. Japan
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Japan Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.3. China
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. China Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. India Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Australia Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Competitive Scenario
9.5.6.3. Thailand Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Competitive Scenario
9.5.7.3. South Korea Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Latin America Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Brazil Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Argentina Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. MEA Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.2. South Africa
9.7.2.1. Key Country Dynamics
9.7.2.2. Competitive Scenario
9.7.2.3. South Africa Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key Country Dynamics
9.7.3.2. Competitive Scenario
9.7.3.3. Saudi Arabia Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Competitive Scenario
9.7.4.3. UAE Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Competitive Scenario
9.7.5.3. Kuwait Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Bio-Rad Laboratories, Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Pacific Biosciences of California, Inc.
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. QIAGEN
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Eurofins Scientific
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Partek Incorporated
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. F. Hoffmann-La Roche Ltd.
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Illumina, Inc.
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Agilent Technologies Inc.
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. DNASTAR, Inc
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
1.1. Market Segmentation and Scope
1.1.1. Product Segment
1.1.2. Workflow Segment
1.1.3. Mode Segment
1.1.4. Read Length Segment
1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Demand for efficient algorithms and tools for analysis of large amount of data generated by sequencers
3.2.1.2. Introduction of technological advancements in cloud computing and data integration
3.2.1.3. Increasing penetration of the NGS technology in personalized medicine and precision diagnosis
3.2.1.4. Rising academic research based on NGS protocols
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges in sequence compression and data storage
3.2.2.2. Selection of appropriate algorithms and parallelizing scientific workflows
3.2.2.3. Budget and time constraints
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. PRODUCT GROUP BUSINESS ANALYSIS
4.1. Product Segment Dashboard
4.2. Next-generation Sequencing Data Analysis Market Product Movement Analysis
4.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Services
4.4.1. Services market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. NGS Commercial Software
4.5.1. NGS commercial software market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2. Platform OS/UI
4.5.2.1. Platform OS/UI market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Analytical Software
4.5.3.1. Analytical software market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.2. QC/pre-processing tools
4.5.3.2.1. QC/pre-processing tools market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3. Alignment tools & software
4.5.3.3.1. Alignment tools & software market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3.2. DNA sequencing alignment
4.5.3.3.2.1. DNA sequencing alignment market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3.3. RNA sequencing alignment
4.5.3.3.3.1. RNA sequencing alignment market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3.4. Protein sequencing alignment
4.5.3.3.4.1. Protein sequencing alignment market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.4. Others
4.5.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. WORKFLOW GROUP BUSINESS ANALYSIS
5.1. Workflow Segment Dashboard
5.2. Next-generation Sequencing Data Analysis Market Workflow Movement Analysis
5.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Primary
5.4.1. Primary market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Secondary
5.5.1. Secondary market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. Read Mapping
5.5.2.1. Read mapping market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Variant Alignment & Variant Calling
5.5.3.1. Variant alignment & variant calling market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Tertiary
5.6.1. Tertiary market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Variant Annotation
5.6.2.1. Variant annotation market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. Application Specific
5.6.3.1. Application specific market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.2. Targeted Sequencing/Gene Panel
5.6.3.2.1. Targeted sequencing/gene panel market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.3. Exome
5.6.3.3.1. Exome market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.4. RNA Sequencing
5.6.3.4.1. RNA sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.5. Whole Genome
5.6.3.5.1. Whole genome market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.6. Chip Sequencing
5.6.3.6.1. Chip sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3.7. Others
5.6.3.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. MODE GROUP BUSINESS ANALYSIS
6.1. Mode Segment Dashboard
6.2. Next-generation Sequencing Data Analysis Market Mode Movement Analysis
6.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
6.4. In-house Data Analysis
6.4.1. In-house data analysis market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Outsourced Data Analysis
6.5.1. Outsourced data analysis market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. READ LENGTH GROUP BUSINESS ANALYSIS
7.1. Read Length Segment Dashboard
7.2. Next-generation Sequencing Data Analysis Market Read Length Movement Analysis
7.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by Read Length, 2018 to 2030 (USD Million)
7.4. Short Read Sequencing
7.4.1. Short read sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Long Read Sequencing
7.5.1. Long read sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Very Long Read Sequencing
7.6.1. Very long read sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. END USE BUSINESS ANALYSIS
8.1. End Use Segment Dashboard
8.2. Next-generation Sequencing Data Analysis Market End Use Movement Analysis
8.3. Next-generation Sequencing Data Analysis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Academic Research
8.4.1. Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Clinical Research
8.5.1. Clinical research market estimates and forecasts, 2018–2030 (USD Million)
8.6. Hospitals & Clinics
8.6.1. Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Pharma & Biotech Entities
8.7.1. Pharma& biotech entities market estimates and forecasts, 2018–2030 (USD Million)
8.8. Other
8.8.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. REGIONAL BUSINESS ANALYSIS BY PRODUCT, WORKFLOW, MODE, READ LENGTH, END USE
9.1. Regional Dashboard
9.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
9.3. North America
9.3.1. North America Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. U.S. Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Canada Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Mexico Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. Europe Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. UK Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Germany Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. France Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Italy Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Spain Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Denmark Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Competitive Scenario
9.4.8.3. Sweden Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Competitive Scenario
9.4.9.3. Norway Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.2. Japan
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Japan Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.3. China
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. China Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. India Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Australia Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Competitive Scenario
9.5.6.3. Thailand Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Competitive Scenario
9.5.7.3. South Korea Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Latin America Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Brazil Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Argentina Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. MEA Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.2. South Africa
9.7.2.1. Key Country Dynamics
9.7.2.2. Competitive Scenario
9.7.2.3. South Africa Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key Country Dynamics
9.7.3.2. Competitive Scenario
9.7.3.3. Saudi Arabia Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Competitive Scenario
9.7.4.3. UAE Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Competitive Scenario
9.7.5.3. Kuwait Next-generation Sequencing Data Analysis Market, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Bio-Rad Laboratories, Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Pacific Biosciences of California, Inc.
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. QIAGEN
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Eurofins Scientific
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Partek Incorporated
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. F. Hoffmann-La Roche Ltd.
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Illumina, Inc.
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Agilent Technologies Inc.
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. DNASTAR, Inc
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
